Sanofi India Ltd. (SANOFI): Sanofi India Share Price near 52-week low as SANOFI trades at Rs 3,095.25

Sanofi India Share Price is under pressure today, with SANOFI last seen at Rs 3,095.25, down 0.47%, while staying close to its 52-week low and carrying a market capitalisation of Rs 7,209.16 crore. The latest move keeps Sanofi India Share Price in focus for investors tracking one-year low setups, especially because the price is now below key long-term averages and near the lower end of its recent range.

The latest Sanofi India Stock News confirms the price event, but the supplied data does not establish a company-specific catalyst. What it does show is a cautious market tone around Sanofi India Share Price Today, with modest turnover of Rs 0.12 crore and a subdued close-to-low session. For readers following Sanofi India Share Price Live, the immediate story is price action, valuation, and healthcare-sector context rather than a fresh event-driven trigger. Univest is tracking this move as part of its near 52-week low coverage framework.

Sanofi India Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 3,095.25
Previous Close	Rs 3,109.8
Today's Move	Rs -14.55 (-0.47%)
Open	Rs 3,083.2
High	Rs 3,122.95
Low	Rs 3,083.2
Turnover	Rs 0.12 crore
Market Capitalisation	Rs 7,209.16 crore

Sanofi India Ltd. (SANOFI) traded at Rs 3,095.25 versus the previous close of Rs 3,109.8, a fall of 0.47%. The stock opened at Rs 3,083.2, reached a high of Rs 3,122.95, touched a low of Rs 3,083.2.

Sanofi India Share Price Today opened at Rs 3,083.20, moved between Rs 3,083.20 and Rs 3,122.95, and ended at Rs 3,095.25 versus the previous close of Rs 3,109.80. That means the stock slipped Rs 14.55, or 0.47%, and stayed close to the day's lower band, which is consistent with a cautious intraday tone.

Turnover stood at Rs 0.12 crore, while market capitalisation was Rs 7,209.16 crore. Because the stock is trading near its 52-week low, this price action matters even without a fresh catalyst: the market is still pricing SANOFI defensively. For anyone scanning Sanofi India Share Price Update, the important takeaway is that the session shows selling pressure at lower levels rather than a broad recovery attempt. The next layer is whether the technical picture confirms weak momentum or simply a short-term pause.

Sanofi India Ltd. (SANOFI) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 7,209.16 crore
P/E Ratio	22.12x
P/B Ratio	8.67x
ROE	44.5%
ROCE	55.46%
EPS	Rs 140.6
Book Value Per Share	Rs 358.67
Dividend Yield	3.96%

Sanofi India Ltd. (SANOFI) fundamental metrics show P/E 22.12x, P/B 8.67x, ROE 44.5%, ROCE 55.46%. These figures provide context only and are not a buy or sell signal.

Sanofi India Ltd. has a market capitalisation of Rs 7209.16 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 22.12x, P/B at 8.67x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 44.5% and ROCE of 55.46%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 140.6, book value per share of Rs 358.67, dividend yield of 3.96%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	22.12x
Benchmark Median P/E	28.19x
Benchmark Average P/E	40.5x
Benchmark P/E Range	0x to 661.74x
Company P/B Ratio	8.67x
Benchmark Median P/B	2.92x
Company ROE	44.5%
Benchmark Median ROE	11.7%
Company ROCE	55.46%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 7,209.16 crore
Benchmark Median Market Cap	Rs 730.86 crore

Sanofi India Ltd. (SANOFI) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Sanofi India Ltd. (SANOFI) has a P/E ratio of 22.12x, which is below the benchmark median of 28.19x, a difference of -21.53%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sanofi India Ltd. (SANOFI) has a ROE of 44.5%, which is above the benchmark median of 11.7%, a difference of +280.34%. Sanofi India Ltd. (SANOFI) has a ROCE of 55.46%, which is above the benchmark median of 13.61%, a difference of +307.49%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Aarti Pharmalabs Ltd.	AARTIPHARM	7,157.36	34.58	3.37	8.5	10.77
Bliss GVS Pharma Ltd.	BLISSGVS	7,297.99	53.08	5.86	12.11	17.4
Supriya Lifescience Ltd.	SUPRIYA	7,080.07	35.69	5.79	19.06	25.3
SYMBIOTEC PHARMALAB LTD	SYMBIOTEC	6,945.44	60.95	4.51	11.22	12.41
SENORES PHARMACEUTICALS L	SENORES	6,543.06	49.94	6.55	14.14	15.66

Sanofi India Ltd. (SANOFI) has a P/E ratio of 22.12x compared with the displayed peer median of 49.94x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 44.5% compares with a peer median of 12.11% across the companies shown in the table. ROCE stood at 55.46% versus the displayed peer median of 15.66%, providing a capital-efficiency comparison. Sanofi India Ltd. (SANOFI) has a market capitalisation of Rs 7,209.16 crore. Among the 5 peers shown, 1 have a larger market capitalisation.

Why Investors Are Watching Sanofi India

• Sanofi India Share Price is trading near its 52-week low, keeping price action in focus for market watchers.
• RSI at 39.4 shows weak momentum, while the stock remains below the 50 DMA and 200 DMA.
• P/E of 22.12 is below the same-industry median of 28.19, while ROE and ROCE remain strong.
• Market cap of Rs 7,209.16 crore and dividend yield of 3.96% add context to the Sanofi India Share Price debate.
• The healthcare sector and pharmaceuticals industry comparison helps explain why Sanofi India Stock News is drawing attention.

About Sanofi India

Sanofi India Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied company data, the business sits within a large healthcare peer set and is assessed through standard market measures such as earnings, book value, return ratios and valuation multiples. For readers researching Sanofi India Share Price, the company profile matters because pharma stocks are often judged on profitability, capital efficiency, pricing power and sector positioning.

The latest financial indicators supplied for Sanofi India show revenue of Rs 4,377 crore for Jun 2026, compared with Rs 4,063 crore in Jun 2025, Rs 4,754 crore in Sep 2025, Rs 4,198 crore in Dec 2025 and Rs 4,723 crore in Mar 2026. Net profit was Rs 835 crore in Jun 2026 versus Rs 695 crore in Jun 2025, Rs 760 crore in Sep 2025, Rs 617 crore in Dec 2025 and Rs 1,026 crore in Mar 2026. That operating backdrop gives Sanofi India Share Price broader context beyond a single trading session, which is why Univest keeps the company on its stock analysis radar.

Track Sanofi India Share Price on Univest

Use Sanofi India Ltd. (SANOFI) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Investors can track Sanofi India Share Price on Univest for live share price updates, key ratios, 52-week levels, shareholding pattern insights, technical indicators and fundamental analysis. Univest also helps users follow Sanofi India Share Price Today alongside Sanofi India Stock News, sector context and peer comparison in one place, making it easier to monitor the stock without chasing scattered market updates.

Frequently Asked Questions

Why is Sanofi India Share Price falling today?

Ans. The supplied data shows Sanofi India Share Price down 0.47% at Rs 3,095.25, but it does not establish a company-specific catalyst. The move mainly reflects weak price action near the 52-week low.

What is the current Sanofi India Share Price?

Ans. Sanofi India Share Price is Rs 3,095.25 in the latest update. It is trading below the previous close of Rs 3,109.80 and remains near its 52-week low, which keeps investor attention elevated.

How did SANOFI perform in today's session?

Ans. SANOFI opened at Rs 3,083.20, touched a high of Rs 3,122.95 and a low of Rs 3,083.20, before closing at Rs 3,095.25. The session ended with a decline of Rs 14.55.

Is Sanofi India Share Price near a 52-week low?

Ans. Yes, the stock is trading near its 52-week low, one-year low and yearly low. That makes Sanofi India Share Price a stock market today watchpoint for traders and long-term investors.

What is Sanofi India's market capitalisation?

Ans. Sanofi India has a market capitalisation of Rs 7,209.16 crore. Market cap shows company size in the market, and it helps frame Sanofi India Share Price against sector peers and benchmark ranges.

Is Sanofi India expensive or cheap on valuation?

Ans. Sanofi India trades at a P/E of 22.12, below the industry median of 28.19, while its P/B of 8.67 is above the median of 2.92. Valuation therefore looks mixed rather than one-sided.

How strong are Sanofi India's profitability ratios?

Ans. ROE is 44.5% and ROCE is 55.46%, both strong relative to the same-industry median. These figures suggest high capital efficiency, which gives Sanofi India Share Price useful fundamental support. ROE stands at 44.5%.

Where can investors track Sanofi India Share Price news?

Ans. Investors can follow Sanofi India Share Price news on Univest for live price tracking, stock analysis, sector context and key ratios. It is useful for monitoring SANOFI alongside healthcare peers and broader market updates.